WS #10408
FT reports AbbVie close to acquiring Apogee Therapeutics for nearly $11B, sending APGE shares up 56% premarket.
AbbVie-Apogee M&A
FT reports AbbVie close to acquiring Apogee Therapeutics for nearly $11B, sending APGE shares up 56% premarket.